NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/26/2022
Back to search
Official data from USPTO
MEDTHINK SCICOM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDTHINK SCICOM
ST13
US500000085032670Class
35, 41
Filing
85032670
Registration
4122347
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/26/2022
Trademark type
Word
Nice classes
35, 41
Filing date
05/07/2010
Registration date
04/03/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2022
Last transaction
03/26/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/16/2010
First use in commerce
08/01/2010
Drawing code
4
Owner type
03
Owner location
Cary, NC, US
Examiner
VANSTON, KATHY
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MEDTHINK, INC.
MedThink Communications, Inc.
Representatives
Neal Wolgin Tillman, Wright & Wolgin
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consultation servicesidentifying and ranking of opinion leaders in the fields of pharmaceuticals and healthcare for the purpose of matching opinion leaders and other experts for positions on business and scientific advisory boards and other business consulting engagements; providing market intelligence and business communications strategies and advisory board developmentproviding competitive business analysis information to advisory boards in the fields of pharmaceuticals and healthcare
Class 41
medical writing servicescustom writing of investigational drug protocolsbiostatistical analysisclinical data managementdrug safety and monitoring board reportsintegrated summaries of safetyintegrated summaries of efficacysafety narrativesother regulatory reports
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/26/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/26/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/26/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/19/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/03/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/02/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/02/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/02/2018
E815
TEAS SECTION 8 & 15 RECEIVED
01/17/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/03/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/26/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/28/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/27/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/22/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/21/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/21/2012
IUAF
USE AMENDMENT FILED
01/22/2012
EISU
TEAS STATEMENT OF USE RECEIVED
01/22/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2011
PUBO
PUBLISHED FOR OPPOSITION
06/14/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/06/2011
ALIE
ASSIGNED TO LIE
05/06/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/21/2011
DOCK
ASSIGNED TO EXAMINER
04/11/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
03/29/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/29/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
03/29/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/29/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2010
GNRT
NON-FINAL ACTION E-MAILED
08/20/2010
CNRT
NON-FINAL ACTION WRITTEN
08/20/2010
DOCK
ASSIGNED TO EXAMINER
08/19/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
05/15/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2010
NWAP
NEW APPLICATION ENTERED
05/11/2010
Continuous trademark protection
Get notified about every new filing that threatens MEDTHINK SCICOM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.